Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Phytother Res ; 37(5): 1951-1967, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36631974

RESUMO

Increased glycolytic in fibroblast-like synoviocytes (FLS) of rheumatoid arthritis (RA) not only contributes to early-stage disease pathogenesis but leads to sustained proliferation of FLS. Given the importance of PKM2 in glycolysis and apoptosis, PKM2 is considered a potential therapeutic and drug discovery target in RA. Total saponins of anemarrhena (TSA), a class of steroid saponins, originated from Anemarrhena asphodeloides Bge. In this study, we verified that 200 mg/kg TSA could significantly alleviate inflammation and the pathological characteristics of RA and inhibit synovial hyperplasia in AA rats. We confirmed that sarsasapogenin (SA) was the principal active ingredient absorbed into the blood of TSA by the UPLC/Q Exactive MS test. Then we used TNF-α-induced MH7A to get the conclusion that 20 µM SA could effectively inhibit the glycolysis by inhibiting the activity of PKM2 tetramer and glucose uptake. Moreover, 20 µM SA could suppress proliferation, migration, invasion, and cytokine release of FLS, interfere with the growth cycle of FLS, and induce FLS apoptosis by depressing the phosphorylation of PKM2. At last, In-1, a potent inhibitor of the PKM2 was used to reverse verify the above results. Taken together, the key mechanisms of SA on RA treatment through downregulating the activity of PKM2 tetramer and phosphorylation of PKM2 inhibited pathological glycolysis and induced apoptosis to exert inhibition on the proliferation and invasion of RA FLS.


Assuntos
Anemarrhena , Artrite Reumatoide , Sinoviócitos , Animais , Ratos , Anemarrhena/química , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/patologia , Proliferação de Células , Células Cultivadas , Fibroblastos , Glicólise , Membrana Sinovial , Saponinas/farmacologia
2.
Int J Food Microbiol ; 377: 109782, 2022 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-35691138

RESUMO

Postharvest rot of potato tubers caused by fungal pathogens is the main cause of significant economic losses, while also raising potential food safety issues. Integrated disease management, utilizing bio-safe and eco-friendly methods, represents a sustainable strategy for reducing postharvest losses in crops, including potato. In the current study, the application of the antagonistic yeast, Wickerhamomyces anomalus, combined with a UV-C treatment was evaluated for the management of postharvest Alternaria rot of potato tubers, caused by Alternaria tenuissima. Both W. anomalus and UV-C as individual treatments reduced the size of A. tenuissima infections on potato tubers, relative to the control, while the combined treatment of W. anomalus and UV-C exhibited the highest level of inhibition. W. anomalus or UV-C alone, and especially when used in combination, induced the expression of defense-related genes, including polyphenol oxidase, peroxidase, and ß-1,3-glucanase, and also increased the level of flavonoids and lignin in potato tubers. Our findings indicate that the mechanism of action by which UV-C enhances the biocontrol effect of W. anomalus against postharvest Alternaria rot includes the activation of defense-related response in potato tubers. The integration of biocontrol agents and physical treatments (e.g., UV-C) represents an effective, eco-friendly hurdle technology for managing postharvest rot in potato.


Assuntos
Alternaria , Solanum tuberosum , Alternaria/fisiologia , Doenças das Plantas/microbiologia , Doenças das Plantas/prevenção & controle , Saccharomycetales , Solanum tuberosum/microbiologia , Leveduras/fisiologia
3.
Front Aging Neurosci ; 14: 873929, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35431901

RESUMO

Energy metabolism disturbance and the consequent reactive oxygen species (ROS) overproduction play a key and pathogenic role in the onset and progression of Alzheimer's disease (AD). Dihuang-Yinzi (DHYZ) is a traditional Chinese herbal prescription clinically applied to treat AD and other neurodegenerative diseases for a long time. However, the systematical metabolic mechanism of DHYZ against AD remains largely unclear. Here we aimed to explore the mechanism of DHYZ in the treatment of AD comprehensively in an in vivo metabolic context by performing metabolomics analysis coupled with network pharmacology study and experimental validation. The network pharmacology was applied to dig out the potential target of DHYZ against AD. The metabolomics analysis based on UPLC-HRMS was carried out to profile the urine of 2× Tg-AD mice treated with DHYZ. By integrating network pharmacology and metabolomics, we found DHYZ could ameliorate 4 key energy-related metabolic pathways, including glycerophospholipid metabolism, nicotinate/nicotinamide metabolism, glycolysis, and tricarboxylic acid cycle. Besides, we identified 5 potential anti-AD targets of DHYZ, including DAO, HIF1A, PARP1, ALDH3B2, and ACHE, and 14 key differential metabolites involved in the 4 key energy-related metabolic pathways. Furthermore, DHYZ depressed the mitochondrial dysfunction and the resultant ROS overproduction through ameliorating glycerophospholipid metabolism disturbance. Thereby DHYZ increased nicotinamide adenine dinucleotide (NAD+) content and promoted glycolysis and tricarboxylic acid (TCA) cycle, and consequently improved oxidative phosphorylation and energy metabolism. In the present study, we provided a novel, comprehensive and systematic insight into investigating the therapeutic efficacy of DHYZ against AD via ameliorating energy-related metabolism.

4.
Oxid Med Cell Longev ; 2021: 5590745, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34306310

RESUMO

Multi-infarct dementia (MID), a prominent subtype of vascular dementia (VD), is responsible for at least 15 to 20 percent of dementia in the elderly. Mitochondrial dysfunctions and glutamate neurotoxicity due to chronic hypoperfusion and oxidative stress were regarded as the major risk factors in the pathogenesis. Kaixin San (KXS), a classic prescription of Beiji Qianjin Yaofang, was applied to treatment for "amnesia" and has been demonstrated to alleviate the cognitive deficit in a variety of dementias, including MID. However, little is known whether mitochondria and glutamate are associated with the protection of KXS in MID treatment. The aim of this study was to investigate the role of KXS in improving the cognitive function of MID rats through strengthening mitochondrial functions and antagonizing glutamate neurotoxicity via the Shh/Ptch1 signaling pathway. Our data showed that KXS significantly ameliorated memory impairment and hippocampal neuron damage in MID rats. Moreover, KXS improved hippocampal mitochondrial functions by reducing the degree of mitochondrial swelling, increasing the mitochondrial membrane potential (MMP), and elevating the energy charge (EC) and ATP content in MID rats. As expected, the concentration of glutamate and the expression of p-NMDAR1 were significantly reduced by KXS in the brain tissue of MID rats. Furthermore, our results showed that KXS noticeably activated the Shh/Ptch1 signaling pathway which was demonstrated by remarkable elevations of Ptch1, Smo, and Gli1 protein levels in the brain tissue of MID rats. Intriguingly, the inhibition of the Shh signaling pathway with cyclopamine significantly inhibited the protective effects of KXS on glutamate-induced neurotoxicity in PC12 cells. To sum up, these findings suggested that KXS protected MID rats from memory loss by rescuing mitochondrial functions as well as against glutamate neurotoxicity through activating Shh/Ptch1 signaling pathway.


Assuntos
Disfunção Cognitiva/metabolismo , Demência por Múltiplos Infartos/metabolismo , Medicamentos de Ervas Chinesas/farmacologia , Ácido Glutâmico/farmacologia , Mitocôndrias/efeitos dos fármacos , Receptor Patched-1/efeitos dos fármacos , Animais , Disfunção Cognitiva/induzido quimicamente , Demência por Múltiplos Infartos/induzido quimicamente , Modelos Animais de Doenças , Ácido Glutâmico/metabolismo , Masculino , Transtornos da Memória/induzido quimicamente , Transtornos da Memória/metabolismo , Mitocôndrias/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Receptor Patched-1/metabolismo , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos
5.
Food Funct ; 12(21): 10443-10458, 2021 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-34231604

RESUMO

Zanthoxylum bungeanum Maxim (Rutaceae), a medicinal herb and foodstuff, has previously been demonstrated as useful for the potential prevention of age-related cognitive dysfunction. However, the mechanisms and material basis remain elusively understood. The prevention of cognitive impairment by four fractions of Z. bungeanum was evaluated in D-galactose-induced aging mice, including petroleum ether (PE), methylene chloride (DCM), ethyl acetate (EA), and n-butanol (N-BAI). The results showed that mice treated with EA and N-BAI had significantly alleviated D-galactose-induced memory deficit. In addition, EA could clearly protect neurons from cell death, alleviate oxidative damage and inhibit the activation of microglia in aging mice. Our data also showed that the activation of the NLRP3 inflammasome, the expression of pyroptosis-related proteins, and the release of IL-1ß and IL-18 could be remarkably inhibited by the EA fraction in aging mice and LPS/ATP-induced BV-2 microglial cells. Besides, the chemical composition of an active EA fraction was qualitatively analyzed by using HPLC-MS/MS. Thirty-four compounds were tentatively identified based on their retention times, accurate mass, and MS/MS spectra. Moreover, eighteen reference compounds were analyzed by HPLC-MS/MS and their contents of EA were determined. The work demonstrated that the ethyl acetate fraction of Bungeanum ameliorated cognitive deficits, and its effects may be related to ameliorating oxidative stress and suppressing the NLRP3 inflammasome pathway and GSDMD-mediated pyroptosis in aging mice.


Assuntos
Disfunção Cognitiva/prevenção & controle , Inflamassomos/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/efeitos dos fármacos , Extratos Vegetais/farmacologia , Piroptose/efeitos dos fármacos , Zanthoxylum/metabolismo , Acetatos , Envelhecimento , Animais , Modelos Animais de Doenças , Camundongos , Extratos Vegetais/metabolismo , Transdução de Sinais
6.
World J Clin Cases ; 9(35): 10781-10791, 2021 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-35047590

RESUMO

Helicobacter pylori (H. pylori) has a high rate of infection and antibiotic resistance and poses a serious threat to human life. One of the main strategies to overcome drug resistance is to develop new treatment plans. Traditional Chinese medicine (TCM) that is commonly used to treat many diseases in China can reduce drug resistance and increase the eradication rate of H. pylori. In this paper, we review the research progress on TCM in the treatment of H. pylori infection. The mechanism of action of TCM is reviewed and research and applications of TCM in the treatment of H. pylori are demonstrated. Finally, we discuss problems confronting the use of TCM for the treatment of H. pylori infection and propose possible solutions. In addition, the plans of TCM in H. pylori treatment were also screened: Dampness-heat syndrome in the spleen and stomach, deficiency of spleen and stomach, and cold-heat complicated syndrome, and the effective components therein are studied. The antibacterial effect of TCM is relatively slow; for rapid improvement of the treatment effect of refractory H. pylori gastritis, we provide an appropriate treatment regime combining TCM and Western medicine with immune-regulatory and synergistic antibacterial effects.

7.
Curr Pharm Des ; 25(3): 359-369, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30864498

RESUMO

Prunella vulgaris (PV) is a perennial herb belonging to the Labiate family and is widely distributed in the northeastern Asian countries such as Korea, Japan, and China. It is reported to display diverse biological activities including anti-microbial, anti-cancer, and anti-inflammation as determined by in vitro or in vivo studies. So far, about 200 compounds have been isolated from PV plant and a majority of these have been characterized mainly as triterpenoids, sterols and flavonoids, followed by coumarins, phenylpropanoids, polysaccharides and volatile oils. This review summarizes and analyzes the current knowledge on the chemical constituents, pharmacological activities, mechanisms of action and clinical applications of the PV plant including its potential as a future medicinal plant. Although some of the chemical constituents of the PV plant and their mechanisms of action have been investigated, the biological activities of many of these remain unknown and further clinical trials are required to further enhance its reputation as a medicinal plant.


Assuntos
Compostos Fitoquímicos/farmacologia , Extratos Vegetais/farmacologia , Prunella/química , Ásia , Plantas Medicinais/química
8.
Int Ophthalmol ; 38(5): 2053-2060, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28852897

RESUMO

PURPOSE: In this study, we elucidated the effects of berberine, a major alkaloid component contained in medicinal herbs, such as Phellodendri Cortex and Coptidis Rhizoma, on expression of monocyte chemotactic protein-1 (MCP-1) and interleukin-8 (IL-8) in a human retinal pigment epithelial cell line (ARPE-19) caused by lipopolysaccharide (LPS) stimulation. METHODS: ARPE-19 cells were cultured to confluence. Berberine and LPS were added to the medium. MCP-1 and IL-8 mRNA were measured by real-time polymerase chain reaction. MCP-1 and IL-8 protein concentrations in the media were measured using enzyme-linked immunosorbent assay. RESULTS: After stimulation with LPS, MCP-1 and IL-8 mRNA in ARPE-19 cells reached maximum levels at 3 h, and MCP-1 and IL-8 protein in the culture media reached maximum levels at 24 h. Berberine dose-dependently inhibited MCP-1 and IL-8 mRNA expression of the cells and protein levels in the media stimulated with LPS. CONCLUSIONS: These findings indicate that berberine inhibited the expression of MCP-1 and IL-8 induced by LPS.


Assuntos
Berberina/farmacologia , Quimiocina CCL2/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Interleucina-8/genética , Degeneração Macular/genética , Epitélio Pigmentado Ocular/metabolismo , RNA/genética , Células Cultivadas , Quimiocina CCL2/biossíntese , Ensaio de Imunoadsorção Enzimática , Humanos , Interleucina-8/biossíntese , Lipopolissacarídeos/farmacologia , Degeneração Macular/metabolismo , Degeneração Macular/patologia , Epitélio Pigmentado Ocular/efeitos dos fármacos , Epitélio Pigmentado Ocular/patologia
9.
Neurosci Lett ; 630: 101-108, 2016 Sep 06.
Artigo em Inglês | MEDLINE | ID: mdl-27461792

RESUMO

Tongluo Xingnao Effervescent Tablet (TXET), a traditional Chinese herbal formula composed of Ligusticum chuanxiong hor, Scutellaria baicalensis Georgi and Angelica sinensis, has been widely used to treat Alzheimer's disease (AD) and related dementias for decades in China. In the present study, we investigated the effects of TXET on mitochondrial function, energy metabolism and cognitive amelioration in the APPswe/PS1De9 transgenetic mouse model of AD. The energy charge and phosphocreatine, activity of the mitochondrial electron transport chain complexes, mitochondrial membrane potential, activity of Na(+)-K(+) ATPase and the expression levels of Bcl-2 and Bax in the brains were measured, respectively. TXET exhibits significant protection on mitochondrial function and energy supply in addition to ameliorating cognitive decline in APPswe/PS1De9 mice. TXET rescues mitochondrial function by increasing the mitochondrial membrane potential, energy charge levels, activity of respiratory chain complexes and Na(+)-K(+) ATPase activity. These findings suggest that TXET may attenuate cognition impairment through the restoration of mitochondrial function and energy metabolism in the brains in APPswe/PS1De9 mice.


Assuntos
Doença de Alzheimer/metabolismo , Transtornos Cognitivos/metabolismo , Medicamentos de Ervas Chinesas/administração & dosagem , Metabolismo Energético/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Doença de Alzheimer/complicações , Doença de Alzheimer/prevenção & controle , Precursor de Proteína beta-Amiloide/genética , Animais , Apoptose/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Transtornos Cognitivos/complicações , Transtornos Cognitivos/psicologia , Modelos Animais de Doenças , Transporte de Elétrons/efeitos dos fármacos , Humanos , Masculino , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Presenilina-1/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , ATPase Trocadora de Sódio-Potássio/metabolismo , Memória Espacial/efeitos dos fármacos , Comprimidos/administração & dosagem , Proteína X Associada a bcl-2/metabolismo
10.
J Int Med Res ; 41(2): 410-7, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23569039

RESUMO

OBJECTIVE: To assess long-term effects of biofeedback training on pubertal chronic prostatitis (CP). METHODS: Pubertal CP patients received 12-week intensive biofeedback training and were divided into two groups: group 1 received further monthly training ≥ 24 (26-36) months; group 2 received further monthly training <24 (13-23) months. National Institutes of Health-CP Symptom Index (NIH-CPSI) scores, maximum urinary flow rate (Qmax) and postvoid residual urine volume (PVR) were recorded monthly. RESULTS: Total NIH-CPSI scores decreased significantly in group 1 (n = 10; mean age ± SD 16.5 ± 1.1 years) together with all subdomain scores (pain, urination, life impact). Total NIH-CPSI scores increased significantly in group 2 (n = 12; mean age ± SD 16.3 ± 1.2 years) at 30 and 36 months, and were significantly different from group 1 at these time points. Urination and life-impact scores increased significantly and Qmax decreased significantly in group 2 at 30 and 36 months. PVR was unchanged in either group. CONCLUSIONS: Twelve-week intensive biofeedback training requires lengthy consolidation sessions to achieve long-term success. Further investigation should assess longer intervals between consolidation sessions, for improving patient compliance and outcome.


Assuntos
Biorretroalimentação Psicológica , Prostatite/terapia , Puberdade , Adolescente , Doença Crônica , Seguimentos , Humanos , Masculino , National Institutes of Health (U.S.) , Estados Unidos
11.
Zhongguo Zhong Yao Za Zhi ; 38(17): 2863-7, 2013 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-24380312

RESUMO

OBJECTIVE: To study the effect of Tongluo Xingnao effervescent tablet on learning and memory of dementia rats induced by injection of Abeta25-35 in hippocampus and expression of insulin-degrading enzyme in hippocampus, in order to provide basis for preventing and treating senile dementia. METHOD: The dementia rat model was established by injecting Abeta25-35 in hippocampus. The rats were divided into the model control group, the Aricept (1.4 mg x kg(-1)) group, and Tongluo Xingnao effervescent tablet high dose (7.56 g x kg(-1)), middle dose (3.78 g x kg(-1)) and low dose (1.59 g x kg(-1)) groups. A sham operation group was established by injecting normal saline in hippocampus. The rats were orally given drugs for 90 days, once a day. Their learning and memory were tested by using Morris water maze. Immunohistochemistry and image analysis were utilized for a quantitative analysis on the expression of insulin-degrading enzyme in hippocampus. RESULT: Tongluo Xingnao effervescent tablet could significantly shorten the escape latency of rats in the directional navigation test, prolong the retention time in the first quadrant dwell, decrease the retention time in the third quadrant dwell, increase the frequency of crossing the platform, show a more notable statistical significance than the model control group (P < 0.05). Additionally, it could also remarkably increase the average optical density of insulin-degrading enzyme in hippocampus, promote the expression of insulin-degrading enzyme in hippocampus, and show a more notable statistical significance than the model control group (P < 0.05). CONCLUSION: Tongluo Xingnao effervescent tablet has the effects of improving learning and memory capacity of AD rats and promoting the expression of insulin-degrading enzyme in hippocampus. Its effect in promoting intelligence will be related to increased insulin-degrading enzyme in hippocampus.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Hipocampo/efeitos dos fármacos , Insulisina/genética , Aprendizagem/efeitos dos fármacos , Memória/efeitos dos fármacos , Doença de Alzheimer/genética , Doença de Alzheimer/metabolismo , Doença de Alzheimer/psicologia , Animais , Feminino , Hipocampo/metabolismo , Humanos , Insulisina/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley , Comprimidos/administração & dosagem
12.
Nat Prod Res ; 26(7): 643-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21861648

RESUMO

A new compound (1), along with 18 known compounds, was isolated from Caryopteris tangutica. On the basis of spectroscopic methods, with special emphasis on 1D- and 2D-NMR techniques, the structure of the new compound was characterised as 6-hydroxy-6-methylcyclohex-2-en-1-one (1).


Assuntos
Lamiaceae/química , Extratos Vegetais/química , Cicloexenos/química , Cicloexenos/isolamento & purificação , Espectroscopia de Ressonância Magnética , Conformação Molecular
13.
Fitoterapia ; 82(6): 854-60, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21570452

RESUMO

Phytochemical investigation of the ethanol extract of Pedicularis kansuensis Maxim. led to the isolation of one new triterpenoid and two new phenylpropanoid glycosides, along with ten known compounds. Their structures were established by extensive 1D and 2D NMR, as well as other spectrum analysis. Biological evaluation of the three new compounds against Hela cell and Hep-6 cell with MIC values ranging from 9 to 20 µg/ml.


Assuntos
Antineoplásicos/farmacologia , Glicosídeos/farmacologia , Pedicularis/química , Triterpenos/farmacologia , Antineoplásicos/química , Antineoplásicos/isolamento & purificação , Glicosídeos/química , Glicosídeos/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Componentes Aéreos da Planta/química , Extratos Vegetais/química , Triterpenos/química , Triterpenos/isolamento & purificação
14.
Fitoterapia ; 81(7): 948-52, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20600688

RESUMO

Three new diarylheptanoids, together with ten known ones, were isolated from the ethanol extract from the rhizomes of Alpinia officinarum Hance. The structural identification of these compounds was mainly achieved by spectroscopic methods. The new compounds were elucidated as 7-(4", 5"-dihydroxy-3"-methoxyphenyl)-1-phenyl -4-heptene-3-one (1), 1, 7-diphenyl-5-heptene-3-one (2) and 4-phenethyl-1, 7-diphenyl -1-heptene-3, 5-dione (3), respectively. All of the compounds showed antibacterial activity against Helicobactor pylori. Especially, the three new compounds showed strong antibacterial activity against Hp-Sydney strain 1 with the MIC values of 9-12 µg/mL, and against Hp-F44 with the MIC values of 25-30 µg/mL.


Assuntos
Alpinia/química , Antibacterianos/farmacologia , Helicobacter pylori/efeitos dos fármacos , Heptanos/farmacologia , Antibacterianos/química , Antibacterianos/isolamento & purificação , Heptanos/química , Heptanos/isolamento & purificação , Testes de Sensibilidade Microbiana , Estrutura Molecular , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Rizoma
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA